Effect of rimonabant on the high-triglyceride/ low-HDL-cholesterol dyslipidemia, intraabdominal adiposity, and liver fat: the ADAGIO-Lipids trial.
Effect of rimonabant on high triglyceride / low-HDL cholesterol dyslipidemia, intraabdominal adiposity and liver fat : ADAGIO-Lipids trial